Risk assessment of clinically significant portal hypertension by means of hepatosplenic volumetry in compensated cirrhosis

被引：0
|
作者：
Romero Cristobal, Mario [1 ]
Clemente, Ana [1 ]
Ramon Botella, Enrique [2 ]
Ortega, Olga [1 ]
Velilla, Elena [1 ]
Matilla, Ana M. [1 ,3 ]
Marquez, Laura [1 ]
Magdalena Salcedo, Maria [1 ,3 ,4 ]
Alonso, Sonia [1 ]
Vega Catalina, Maria [1 ]
Fernandez, Ainhoa [1 ]
Diaz Fontela, Fernando [1 ]
Ibanez, Luis [1 ]
Rincon, Diego [1 ,3 ]
Banares, Rafael [1 ,3 ,4 ]
机构：
[1] Hosp Gregorio Maranon, Hepatol, Madrid, Spain
[2] Hosp Gregorio Maranon, Radiol, Madrid, Spain
[3] Ciberehd, Madrid, Spain
[4] Univ Complutense, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT178
引用
收藏
页码：S742 / S742
页数：1
相关论文
共 50 条
  • [1] Noninvasive Tools and Risk of Clinically Significant Portal Hypertension and Varices in Compensated Cirrhosis: The "Anticipate" Study
    Abraldes, Juan G.
    Bureau, Christophe
    Stefanescu, Horia
    Augustin, Salvador
    Ney, Michael
    Blasco, Helene
    Procopet, Bogdan
    Bosch, Jaime
    Genesca, Joan
    Berzigotti, Annalisa
    HEPATOLOGY, 2016, 64 (06) : 2173 - 2184
  • [2] NON-INVASIVE TOOLS AND RISK OF VARICES AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN COMPENSATED CIRRHOSIS: THE "ANTICIPATE" STUDY
    Abraldes, J. G.
    Bureau, C.
    Stefanescu, H.
    Augustin, S.
    Ney, M.
    Procopet, B.
    Bosch, J.
    Genesca, J.
    Berzigotti, A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S198 - S199
  • [3] Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis
    Berzigotti, Annalisa
    Gilabert, Rosa
    Abraldes, Juan G.
    Nicolau, Carlos
    Bru, Concepcion
    Bosch, Jaime
    Garcia-Pagan, Juan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1159 - 1167
  • [4] Bulevirtide monotherapy for 48 weeks in HDV patients with compensated cirrhosis and clinically significant portal hypertension
    Degasperi, Elisabetta
    Anolli, Maria Paola
    Sara, Colonia
    Renteria, Uceda
    Sambarino, Dana
    Borghi, Marta
    Perbellini, Riccardo
    Scholtes, Caroline
    Facchetti, Floriana
    Loglio, Alessandro
    Fraquelli, Mirella
    Costantino, Andrea
    Ceriotti, Ferruccio
    Zoulim, Fabien
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2022, 77 : S868 - S868
  • [5] METABOLOMICS IMPROVES THE PREDICTION OF RISK OF DECOMPENSATION OR LIVER RELATED DEATH IN PATIENTS WITH COMPENSATED CIRRHOSIS AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
    Maria Nicoara-Farcau, Oana
    Jose Lozano, Juan
    Sidorova, Julia
    Villanueva Sanchez, Candido
    Albillos, Agustin
    Genesca, Joan
    Luis Calleja, Jose
    Aracil, Carles
    Banares, Rafael
    Maria Morillas, Rosa
    Poca Sans, Maria
    Penas, Beatriz
    Augustin, Salvador
    Perez-Campuzano, Valeria
    Hernandez-Gea, Virginia
    Abraldes, Juan G.
    Alvarado Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    Carlos Garcia-Pagan, Juan
    HEPATOLOGY, 2022, 76 : S155 - S156
  • [6] BACTERIAL INFECTIONS IN PATIENTS WITH COMPENSATED CIRRHOSIS AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION: IMPLICATIONS ON THE RISK OF DEVELOPING DECOMPENSATION AND ON SURVIVAL.
    Villanueva, Candid
    Albillos, Agustin
    Genesca, Joan
    Carlos Garcia-Pagan, Juan
    Luis Calleja, Jose
    Aracil, Carles
    Banares Canizares, Rafael
    Morillas, Rosa
    Poca Sans, Maria
    Penas, B.
    Augustin, Salvador
    Abraldes, Juan G.
    Alvarado Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    HEPATOLOGY, 2019, 70 : 36A - 37A
  • [7] Ultrasound parameters in the prediction of clinically significant portal hypertension (CS-PHT) in compensated cirrhosis.
    Avala, J
    Zalwin, M
    Taylor, C
    Bosch, J
    Groszmann, RJ
    Garcia-Tsao, G
    GASTROENTEROLOGY, 2000, 118 (04) : A968 - A968
  • [8] Pharmacist led telemonitoring and titration of carvedilol for ambulatory patients with compensated cirrhosis and clinically significant portal hypertension
    Rodda, Sheridan
    McAinch, Chloe
    Morgan, Aparna
    Flanagan, Eliza
    Saxby, Edward
    Hunter, Jo
    Kirsa, Sue
    Bell, Sally
    Le, Suong
    JOURNAL OF HEPATOLOGY, 2023, 78 : S16 - S16
  • [9] RISK AND PREDICTORS OF LIVER DECOMPENSATION IN COMPENSATED CIRRHOSIS WITH CLINICALLY SIGNIFICANT PORTAL HYPERTENSION: MAFLD-RELATED VS NON-MAFLD RELATED CIRRHOSIS
    Wong, Yu Jun
    Chen, Kaina
    Tan, Yu Bin
    Tay, Shu Wen
    Teh, Kevin Kim Jun
    Kumar, Rahul
    GASTROENTEROLOGY, 2021, 160 (06) : S854 - S854
  • [10] SPLEEN STIFFNESS MEASUREMENTS (SSM) IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN PATIENTS WITH COMPENSATED CIRRHOSIS
    Ortiz, Guillermo A.
    Palumbo, Chiara
    Sayyar, Mubarak W.
    Balakrishnan, Maya
    Mohanty, Arpan
    Garcia-Tsao, Guadalupe
    GASTROENTEROLOGY, 2020, 158 (06) : S1385 - S1385
12345